• Skip to main content
  • Skip to footer

Akari Therapeutics

AN INNOVATIVE TARGETED ONCOLOGY COMPANY BUILT ON NEXT GENERATION ANTIBODY-DRUG CONJUGATES (ADC) AND A NOVEL DISCOVERY ENGINE

Menu
  • HOME
  • ABOUT
    • Close
    • COMPANY OVERVIEW
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • CEO CORNER
    • SCIENTIFIC ADVISORY BOARD
  • AREAS OF FOCUS
    • Close
    • PIPELINE
    • POSTERS & PUBLICATIONS
  • INVESTOR RELATIONS
    • Close
    • OVERVIEW
    • CORPORATE GOVERNANCE
      • Close
      • GOVERNANCE OVERVIEW
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIAL INFORMATION
      • Close
      • SEC FILINGS
      • ANNUAL REPORTS
    • NEWS & PRESENTATIONS
      • Close
      • PRESS RELEASES
      • PRESENTATIONS
    • ANALYST COVERAGE
    • STOCK INFORMATION
      • Close
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
    • EMAIL ALERTS
  • PRESS
    • Close
    • PRESS RELEASES
  • CONTACT US

Akari TX

Akari TX / October 25, 2021

Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program

Nomacopan eyedrops reduced inflammation more than both standard treatments cyclosporin and the steroid dexamethasone in a model of allergic eye diseaseBuilding …

[Read more...] about Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program

Akari TX / September 22, 2021

Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

NEW YORK and LONDON, September 22, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …

[Read more...] about Akari Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

Akari TX / September 10, 2021

Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference

NEW YORK and LONDON, September 7, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …

[Read more...] about Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference

Akari TX / September 7, 2021

Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference

NEW YORK and LONDON, September 7, 2021 – Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to …

[Read more...] about Akari Therapeutics to Present at the H.C. Wainwright Global Investment Conference

Akari TX / July 7, 2021

Akari Therapeutics Announces Private Placement

NEW YORK and LONDON, July 7, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (“Akari” or the “Company”), a biopharmaceutical company focused on …

[Read more...] about Akari Therapeutics Announces Private Placement

« Previous Page
Next Page »

Footer

FOLLOW US

X
LINKEDIN
Youtube
Terms of Use
Privacy Statement
Contact Us

Akari TX

Copyright © 2026 · Akari Therapeutics · Site Designed by Polus Digital, Inc.